We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Artificial Bone Marrow Generates Functional Immune Cells

By LabMedica International staff writers
Posted on 05 Jan 2009
A recent paper described the development of a method for producing artificial bone marrow capable of generating viable and functional human blood cells in a novel three-dimensional scaffold tissue culture chamber. More...


Artificial marrow could enable the in vitro testing of new drugs to ascertain their effect on bone marrow function. This would facilitate drug development and reveal side effects before human drug trials.

Investigators at the University of Michigan (Ann Arbor, USA) constructed three-dimensional scaffolds with inverted colloidal crystal geometry that mimicked the structural topology of actual bone marrow matrix. The scaffolds were made out of a transparent polymer that allowed the easy passage of nutrients. The scaffolds were molded from a polymer that initially contained tiny spheres ordered like billiard balls. The spheres were then dissolved to leave a well-defined geometry of pores in the scaffold material. The scaffolds were then coated with a layer of transparent nanocomposite to facilitate adhesion of hematopoietic stem cells (HSCs).

Results published in the November 29, 2008, issue of the journal Biomaterials revealed that scaffolds seeded with (HSCs) were capable of supporting expansion of CD34+ HSCs with B-lymphocyte differentiation. The B cells produced antibodies when challenged with a flu virus. Functionality of the artificial bone marrow constructs was confirmed by implantation of scaffolds containing human CD34+ cells onto the backs of severe combined immunodeficiency (SCID) mice with subsequent generation of human immune cells.

"This is the first successful artificial bone marrow," said senior author Dr. Nicholas Kotov, professor of biomedical engineering at the University of Michigan. "Certain stem cells that are essential for immunity and blood production are able to grow, divide, and differentiate efficiently in these scaffolds due to the close similarity of the pores in the scaffold and the pores in actual bone marrow. It has two of the essential functions of bone marrow. It can replicate blood stem cells and produce B cells. The latter are the key immune cells producing antibodies that are important to fighting many diseases."

"The geometrical perfection of the polymer molded by spheres is very essential for reproducibility of drug tests and evaluation of potential drug candidates," said Dr. Kotov. "The scaffold for this work had to be designed from scratch closely mimicking real bone marrow because there are no suitable commercial products."

Related Links:
University of Michigan


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.